Jefferies Financial Group upgraded shares of Nektar Therapeutics (NASDAQ:NKTR – Free Report) from a hold rating to a buy rating in a report issued on Friday, MarketBeat reports. Jefferies Financial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback